Sofinnova Partners

Sofinnova Partners

Portfolio companies

Sofinnova Partners is on record against 59 companies.

AAVantgarde Bio ABIONYX Pharma Abivax Ablynx NV Actithera Addex Therapeutics Advanced Perfusion Diagnostics Afyren Alia Therapeutics Amolyt Pharma Artios Pharma Arzeda Ascendis Pharma Asceneuron Avantium Betteromics BioClec BioCorteX Bionyra Bioptimus Biosyntia Biotalys BiovelocITA Borea Therapeutics Breath Therapeutics BrightHeart Calliditas Catamaran Bio CellCentric CelluComp CinCor Pharma Comet Biorefining CoreValve CorVent Medical Corvidia Therapeutics CorWave Crescendo Biologics Cure51 DBV deepc Delinia DISCO Pharmaceuticals DMC Biotechnologies DNA Script Elevara Medicines Elicit Plant Endoron Medical EnginZyme Enthera Pharmaceuticals ENYO Pharma EOS Excelsior Sciences F2G Forth Therapeutics Freya Biosciences Galvanize Genespire Genset GenSight Biologics
Investment focus

Sofinnova Partners invests across all stages globally, focusing on life sciences and deep tech. The firm targets the Benelux region and beyond, with a portfolio spanning biotech, medtech, and industrial innovations.

Related investors
All investors with a sourced record →
Get a deep full report on Sofinnova Partners → Get warm-intro paths to Sofinnova Partners → See how VCs use MentionFox →
Public profile · MentionFox — investor research, warm-intro mapping, and full reports.